Clinical Trial Update: A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn [Phase 3]

View source ↗

Summary

Phase 3 study of a dexlansoprazole modified-release formulation for night-time gastroesophageal reflux symptoms completed; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• dexlansoprazole modified-release (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2010-05-06